Detection of Cardiac Amyloidosis with Us2.ai –Now FDA cleared and CE marked
AI Echocardiography Tool Now Approved to Help Doctors Detect Cardiac Amyloidosis — A Commonly Missed Heart Disease
Singapore – July 7, 2025 – Us2.ai, a global leader in artificial intelligence (AI) for automated analysis of heart ultrasound scans (echocardiography), has announced that its latest AI Echo Copilot ™ software now includes a feature to assist in the detection of cardiac amyloidosis—a serious and frequently under-diagnosed condition. This new capability has received FDA clearance in the United States and CE mark in Europe, officially authorizing its clinical use in hospitals and healthcare settings worldwide.
